BackCannara Biotech Overview

Cannara Biotech Other Current Assets

Track Cannara Biotech's other current assets ($1.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$1.73M
↓ 73.44% YoYΔ $-4.78M vs prior year quarter

Peer average / median

Loading

Cannara Biotech Other Current Assets History

Loading

Cannara Biotech vs. peers: Other Current Assets Comparison

Loading

Cannara Biotech Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cannara Biotech (LOVFF) FAQ

Cannara Biotech posts a other current assets of $1.7M as of May 2026. That compares with $6.5M in the prior-year period — down 73.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Cannara Biotech's other current assets was $6.5M. The latest reading is $1.7M — a 73.4% year-over-year decrease (period ending May 2026). Use the history and growth charts on this page for a longer lookback.

Other Current Assets is one piece of Cannara Biotech's financial statement story. At $1.7M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for LOVFF's other current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Cannara Biotech's other metric pages and overview cover the third.

Questions & Answers